+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Programmed Cell Death Protein"

Immunotherapy Drugs Market - Global Forecast 2025-2032 - Product Thumbnail Image

Immunotherapy Drugs Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 180 Pages
  • Global
From
Malignant Mesothelioma Market - Global Forecast 2025-2032 - Product Thumbnail Image

Malignant Mesothelioma Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 189 Pages
  • Global
From
Urothelial Cancer Drugs Market - Global Forecast 2025-2032 - Product Thumbnail Image

Urothelial Cancer Drugs Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 195 Pages
  • Global
From
Oncolytic Virus Therapies Market - Global Forecast 2025-2032 - Product Thumbnail Image

Oncolytic Virus Therapies Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 189 Pages
  • Global
From
Immuno-Oncology Market - Global Forecast 2025-2032 - Product Thumbnail Image

Immuno-Oncology Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 197 Pages
  • Global
From
Head & Neck Cancer Drugs Market - Global Forecast 2025-2032 - Product Thumbnail Image

Head & Neck Cancer Drugs Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 199 Pages
  • Global
From
From
Esophageal Cancer Market - Global Forecast 2025-2032 - Product Thumbnail Image

Esophageal Cancer Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 194 Pages
  • Global
From
VEGF Inhibitors for Cancer Market - Global Forecast 2025-2030 - Product Thumbnail Image

VEGF Inhibitors for Cancer Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 185 Pages
  • Global
From
From
Immuno-Oncology Service Market - Global Forecast 2025-2030 - Product Thumbnail Image

Immuno-Oncology Service Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 199 Pages
  • Global
From
From
From
From
Throat Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Throat Cancer Therapeutics - Global Strategic Business Report

  • Report
  • October 2025
  • 267 Pages
  • Global
From
Oncolytic Virotherapy - Global Strategic Business Report - Product Thumbnail Image

Oncolytic Virotherapy - Global Strategic Business Report

  • Report
  • October 2025
  • 243 Pages
  • Global
From
Gastric Cancer - Global Strategic Business Report - Product Thumbnail Image

Gastric Cancer - Global Strategic Business Report

  • Report
  • October 2025
  • 582 Pages
  • Global
From
Oral Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Oral Cancer Therapeutics - Global Strategic Business Report

  • Report
  • October 2025
  • 182 Pages
  • Global
From
Sarcoma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Sarcoma Therapeutics - Global Strategic Business Report

  • Report
  • October 2025
  • 180 Pages
  • Global
From
Soft Tissue Sarcoma - Global Strategic Business Report - Product Thumbnail Image

Soft Tissue Sarcoma - Global Strategic Business Report

  • Report
  • October 2025
  • 282 Pages
  • Global
From
Loading Indicator

Programmed Cell Death Protein (PDP) is a type of protein that plays a role in the regulation of cell death in the body. It is a key component of the body's natural defense against cancer, as it helps to prevent the growth and spread of cancerous cells. In oncology drugs, PDP is used to target and destroy cancer cells, while leaving healthy cells unharmed. PDP is also used to reduce the side effects of chemotherapy and radiation therapy, as well as to reduce the risk of recurrence of cancer. PDP is also used to reduce the risk of metastasis, or the spread of cancer to other parts of the body. PDP is a rapidly growing market, with many companies developing and marketing PDP-based drugs. Some of these companies include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Pfizer. Show Less Read more